Fluosphera sa
WebFeb 8, 2024 · FluoSphera is devising the first-ever liquid microphysiological systems (MPS) to revolutionize drug discovery, increase the success rate of clinical trials, and propose superior alternatives to animal experimentation. WebAusgestellt am 1. April 2024SchweizWO2024058557A1. The invention relates to a multiplexed and encapsulated 3D cell co-culture drug testing or screening method. The …
Fluosphera sa
Did you know?
WebJan 3, 2024 · FluoSphera develops a unique technology platform with the goal to predict the effects of drug candidates much better by mimicking the communications between … WebFluoSphera integrates these three aspects with a systemic approach to better predict the effects of drugs before they reach the patient, thus reducing drug development failure. …
WebFiled in June 13 (2024), the FLUOSPHERA covers Diagnostic biomarkers for analytical, research and scientific use FLUOSPHERA Trademark Application of FluoSphera SA - Serial Number 79361288 :: Justia Trademarks WebFind detailed information on Pharmaceutical and Medicine Manufacturing companies in Plan-les-ouates, Geneve, Switzerland, including financial statements, sales and marketing contacts, top competitors, and firmographic insights.
WebAre you ready for one of the world's most exciting emerging markets? Follow the success of entrepreneurs like Gregory Segala of FluoSphera SA! Apply to be one of 10 Swiss "Scientrepreneurs" who will... WebFluoSphera develops Liquid Microphysiological Systems to better predict the efficacy and safety of candidate drugs with an unprecedented multiplexing capacity. Our LMSs allow …
Webwww.fluosphera.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office Route de la Galaise 34 Plan-les-Ouates 1228 Geneva Switzerland +41 022 000 00 00 FluoSphera Timeline 2024 2024
WebAug 12, 2024 · Gregory Segala (Fluosphera SA, Switzerland) introduced 3D multi-organoid systems for drug discovery — a promising technology with the potential to become a concrete alternative to animal experimentation. Prior to breaking out for the engaging poster session, Remi Villenave (F. Hoffman-La Roche Ltd., Switzerland) presented on the … pops lexington kyshari woutersWebFluoSphera develops a technology platform to predict the effects of drug candidates. Use the CB Insights Platform to explore FluoSphera's full profile. FluoSphera - Products, Competitors, Financials, Employees, Headquarters Locations pop slot cheatsWebJan 3, 2024 · FluoSphera SA. Predictive drug profiling with multi-organoid systems. FluoSphera has developed in vitro human biosystems that mimic essential features of … shari zook confessionsWebFluoSphera SA was delighted to be an invited speaker at the Micronarc Alpine Meeting at Villars-sur-Ollon (Switzerland)! We were impressed by the quality... shari zellers photographyWebCHF 40,000 for boosting health tech innovation through tissue engineering: FluoSphera SA and SensaWear advance to the next stage of Venture Kick. Congratulations to the excellent teams of founders... shariz bannerlordWebThe technology developed by FluoSphera uses microfluidics-based cell encapsulation and high-content imaging to mimic and track … shari zimbelman beyond realty